PEAK6’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.68M Buy
64,600
+6,200
+11% +$553K 0.01% 728
2026
Q1
$4.19M Sell
58,400
-138,500
-70% -$10.7M 0.01% 987
2025
Q4
$15.6M Buy
196,900
+38,800
+25% +$3.06M 0.03% 457
2025
Q3
$11.9M Buy
158,100
+43,500
+38% +$2.98M 0.02% 615
2025
Q2
$7.91M Sell
114,600
-113,500
-50% -$7.44M 0.01% 739
2025
Q1
$15.5M Sell
228,100
-509,200
-69% -$30.5M 0.03% 425
2024
Q4
$33.1M Buy
+737,300
New +$41.4M 0.07% 236

Other funds holding CVS

PEAK6's CVS Position: Q2 2026 in Review

PEAK6 increased its CVS Health (CVS) stake by 307% in Q2 2026, buying an estimated $1.63M and bringing the position to 24,245 shares worth $2.51M. The position accounts for 0.01% of the portfolio, ranked #1200.

PEAK6 first reported a position in CVS in Q4 2024 and has held it in 5 quarters since. The position peaked at $15M in Q4 2024. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • PEAK6 held 24,245 shares of CVS Health worth $2.51M as of Q2 2026.
  • PEAK6 bought 18,285 CVS Health shares in Q2 2026, an estimated $1.63M.
  • CVS Health made up 0.01% of PEAK6's portfolio in Q2 2026, its #1200 holding.
  • PEAK6 first reported a position in CVS Health in Q4 2024 and has held it in 5 quarters since.
  • PEAK6's CVS Health position peaked at $15M in Q4 2024.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.